tiprankstipranks
Advertisement
Advertisement

GILD Stock Latest News

Gilead’s Zamzetoclax Trial Update: What a Terminated Phase 1 Means for GILD Investors
Company AnnouncementsGilead’s Zamzetoclax Trial Update: What a Terminated Phase 1 Means for GILD Investors
3d ago
GILD
Gilead Targets Long-Acting HIV Regimens With New Injectable Study
PremiumCompany Announcements
Gilead Targets Long-Acting HIV Regimens With New Injectable Study
4d ago
GILD
Gilead Expands Oncology Ambitions With New Denikitug Trial in Tough GI Cancers
PremiumCompany Announcements
Gilead Expands Oncology Ambitions With New Denikitug Trial in Tough GI Cancers
10d ago
GILD
Gilead Targets Long-Acting HIV Control With New Injectable Study Versus Biktarvy
PremiumCompany Announcements
Gilead Targets Long-Acting HIV Control With New Injectable Study Versus Biktarvy
10d ago
GILD
Lakefront Biotherapeutics resumed with an Equal Weight at Morgan Stanley
PremiumThe Fly
Lakefront Biotherapeutics resumed with an Equal Weight at Morgan Stanley
10d ago
GILD
LKFT
Gilead price target lowered to $166 from $168 at Morgan Stanley
PremiumThe FlyGilead price target lowered to $166 from $168 at Morgan Stanley
12d ago
GILD
Early notable gainers among liquid option names on July 7th
Premium
The Fly
Early notable gainers among liquid option names on July 7th
13d ago
CHTR
DASH
Gilead price target lowered to $156 from $157 at Truist
Premium
The Fly
Gilead price target lowered to $156 from $157 at Truist
13d ago
GILD
Gilead price target lowered to $120 from $122 at RBC Capital
PremiumThe Fly
Gilead price target lowered to $120 from $122 at RBC Capital
13d ago
GILD
Citizens biotech analyst holds an analyst/industry conference call
PremiumThe Fly
Citizens biotech analyst holds an analyst/industry conference call
14d ago
ALLO
CLLS
Midday Fly By: SK Hynix targets U.S. listing, Lockheed to acquire Ultra Maritime
PremiumThe Fly
Midday Fly By: SK Hynix targets U.S. listing, Lockheed to acquire Ultra Maritime
14d ago
S
BA
Okta upgraded, Datadog downgraded: Wall Street’s top analyst calls
PremiumThe Fly
Okta upgraded, Datadog downgraded: Wall Street’s top analyst calls
14d ago
M
S
Gilead upgraded to Buy from Hold at HSBC
PremiumThe FlyGilead upgraded to Buy from Hold at HSBC
14d ago
GILD
Citizens biotech analysts hold an analyst/industry conference call
Premium
The Fly
Citizens biotech analysts hold an analyst/industry conference call
18d ago
ALLO
CLLS
Unusually active option classes on open June 30th
Premium
The Fly
Unusually active option classes on open June 30th
20d ago
CE
CL
Analyst Reiterates Buy on Gilead, Keeping Yeztugo‑Driven Outlook Intact with Unchanged $168 Price Target
PremiumRatings
Analyst Reiterates Buy on Gilead, Keeping Yeztugo‑Driven Outlook Intact with Unchanged $168 Price Target
20d ago
GILD
Merck says FDA approves Keytruda and Keytruda Qlex in combo with Trodelvy
PremiumThe Fly
Merck says FDA approves Keytruda and Keytruda Qlex in combo with Trodelvy
25d ago
MRK
GILD
FDA approves Gilead’s Trodelvy for two indications
PremiumThe Fly
FDA approves Gilead’s Trodelvy for two indications
26d ago
MRK
GILD
Gilead announces EC grants marketing authorization for Trodelvy
PremiumThe Fly
Gilead announces EC grants marketing authorization for Trodelvy
27d ago
GILD
RedHill (RDHL) Gains FDA Rare Pediatric Disease Designation, Opening Door to Potential Priority Review Voucher (PRV) Upside
PremiumMarket NewsRedHill (RDHL) Gains FDA Rare Pediatric Disease Designation, Opening Door to Potential Priority Review Voucher (PRV) Upside
1M ago
GILD
JAZZ
Gilead announces FDA approval of sNDA for Yeztugo
Premium
The Fly
Gilead announces FDA approval of sNDA for Yeztugo
1M ago
GILD
The Week That Was, The Week Ahead: Macro and Markets, June 14
Premium
Market News
The Week That Was, The Week Ahead: Macro and Markets, June 14
1M ago
CX
KO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >